Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GR Activity in Induced Sputum Macrophages After Symbicort in COPD
NCT01787097Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by Imperial College London. Started Jan 2013; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01787097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787097.